New studies show that legal cannabis access reduces opioid abuse

New studies show that legal cannabis access reduces opioid abuse


 

Scientific data is growing nearly by the day in support of the notion that legalized cannabis can mitigate opioid use and abuse.

For instance, among states where medical cannabis access is permitted, patients routinely lessen their opioid intake. According to data published this week by the Minnesota Department of Health, among those patients known to be taking opiate painkillers upon their enrollment into the program, 63 percent “were able to reduce or eliminate opioid usage after six months.”

Minnesota’s findings are hardly unique. In 2016 there was  data gathered from patients enrolled in Michigan’s cannabis access program reported that marijuana treatment “was associated with a 64 percent decrease in opioid use, decreased number and side effects of medications, and an improved quality of life.”

A review of state-registered patients from various northeastern states yielded similar results, finding, 77 percent of respondents acknowledged having reduced their use of opioids following cannabis therapy.

A significant percentage of respondents also reported decreasing their consumption of anti-anxiety medications (72 percent), migraine-related medications (67 percent), sleep aids (65 percent), and antidepressants (38 percent).

A 2017 assessment of medical cannabis patients in Illinois revealed that participants in the state-run program frequently reported using marijuana "as an alternative to other medications -- most commonly opioids, but also anticonvulsants, anti-inflammatories, and over-the-counter analgesics." 

For the rest of the artilce, see here






Questions?
Click here to chat with us

_